Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency

British Journal of Haematology

Volumn 138, Issue 1, 2007, Pages 94-96

  Kim, J J ^a   Thrasher, A J ^b   Jones, A M ^a   Davies, E G ^a   Cale, C M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autoimmune cytopenias; Children; Immune deficiency; Rituximab

Indexed keywords

RITUXIMAB;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CYTOPENIA; DRUG TOLERABILITY; FATIGUE; FEMALE; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; INFANT; LYMPHOPROLIFERATIVE DISEASE; MALAISE; MALE; NEUTROPENIA; PRIORITY JOURNAL; RELAPSE; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME;

ADOLESCENT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC FACTORS; INFANT; MALE; NEUTROPENIA; THROMBOCYTOPENIA;

EID: 34250009781     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06616.x     Document Type: Article

References (12)

1. Bennett, C.M., Rogers, Z.R., Kinnamon, D.D., Bussel, J.B., Mahoney, D.H., Abshire, T.C., Sawaf, H., Moore, T.B., Loh, M.L., Glader, B.E., McCarthy, M.C., Mueller, B.U., Olson, T.A., Lorenzana, A.N., Mentzer, W.C., Buchanan, G.R., Feldman, H.A. Neufeld, E.J. (2006). Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood, 107, 2639 2642.
2. Heelan, B.T., Tormey, V., Amlot, P., Payne, E., Mehta, A. Webster, A.D. (2002). Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. British Journal of Haematology, 118, 1078 1081.
3. Perotta, S., Locatelli, F., La Manna, A., Cennamo, L., De Stefano, P. Nobili, B. (2002). Anti-CD20 monoclonal antibody (rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. British Journal of Haematology, 116, 465 467.
4. Quartier, P., Brethon, B., Philippet, P., Landman-Parker, J., LeDeist, F. Fischer, A. (2001) Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 358, 1511 1513.
5. Reff, M.E., Carner, K., Chambers, S., Chinn, P.C., Leonard, J.E., Raab, R., Newman, R.A., Hanna, N. Anderson, D.R. (1994) Depletion of B-cells in vivo by a chimeric mouse monoclonal antibody to CD20. Blood, 83, 435 445.
6. Robak, T. (2004). Monoclonal antibodies in the treatment of autoimmune cytopenias. European Journal of Haematology, 72, 79 88.
7. Stasi, R., Pagano, A., Stipa, E. Amadori, S. (2001). Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood, 98, 952 957.
8. Taube, T., Schmid, H., Reinhard, H., von Stackelberg, A. Overberg, U.S. (2005). Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood. Haematologica, 90, 281 283.
9. Wakim, M., Shah, A., Arndt, P.A., Garratty, G., Weinberg, K., Hofstra, T. Church, J. (2004). Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. American Journal of Hematology, 76, 152 155.
10. Wang, J. Cunningham-Rundles, C. (2005). Treatment and outcome of autoimmunehematologic disease in common variable immune deficiency (CVID). Journal of autoimmunity, 25, 57 62.
11. Wang, J., Wiley, J.M., Luddy, R., Greenberg, J., Feuerstein, M.A. Bussel, J.B. (2005). Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. Journal of Pediatrics, 146, 217 221.
12. Zecca, M., Nobili, B., Ramenghi, U., Perrotta, S., Amendola, G., Rosito, P., Jankovic, M., Pierani, P., De Stefano, P., Regazzi Bonora, M. Locatelli, F. (2003). Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood, 101, 3857 3861.